Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzimidazole TRPV1 inhibitors

Benzimidazole TRPV1 inhibitors

US Patent 7612211 · Granted Nov 3, 2009

Estimated economic value: $124,164,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Proteasome activity enhancing compounds2025
Pyrazolopyridinone compounds2023
Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infe2023
Proteasome activity enhancing compounds2023
Quinolinone compounds2022
Pyrazolopyridinone compounds2022
Compounds, compositions, and methods for modulating CFTR2022
Compounds, compositions, and methods for modulating CFTR2021
Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-ind2021
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Compounds, compositions, and methods for increasing CFTR activity2021
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2020